PAX9 and lung carcinoma: PAX9 downregulation could make normal cells susceptible to neoplasia, whereas, when cancer has developed, PAX9 amplification and overexpression could also promote the cancer phenotype (e.g., HNSCC, ESCC, and lung cancer), similar to the case of NOTCH in carcinogenesis [69].